has function has role vaccinated in route immunizes against disease immunizes recipient sarcoma Homo sapiens therapeutic vaccine function vaccine in clinical trial role intradermal route sarcoma cancer vaccine therapeutic cancer vaccine whole cell cancer vaccine tumor lysate/KLH pulsed dendritic cell vaccine 6365 Jie Zheng cancer vaccine A cancer vaccine made from proteins from the patient's tumor cells may boost the body's immune response against the tumor. The effects of chemotherapy on the immune system can potentially make immunotherapy more effective if administered soon after completion of chemotherapy. The addition of recombinant human IL-7 (interleukin 7) (rhIL-7 (recombinant human interleukin 7)) may make the immunotherapy more effective. Alpha cluster of differentiation 25 (CD25) and 8H9 depleted autologous lymphocytes plus tumor lysate/keyhole limpet hemocyanin (KLH) pulsed dendritic cell vaccines plus or minus r-hIL7 (CYT107) may induce immune responses to tumor lysate in patients (with Ewing's sarcoma, rhabdomyosarcoma or neuroblastoma). VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6365 Hayleigh Kahn NCT: https://clinicaltrials.gov/study/NCT00923351